Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
1 clinical trials · Condition
◉ Watch Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| ZR2 Sequential Immunochemotherapy for Newly Treated MCL (NCT05992597) | Zhejiang Cancer Hospital | 2022-08-01 |
Track Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.